Current Report Filing (8-k)
January 26 2017 - 5:08PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
January
23, 2017
EVINE Live Inc.
(Exact name of registrant as specified in
its charter)
Minnesota
|
001-37495
|
41-1673770
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
6740 Shady Oak Road
Eden Prairie, Minnesota 55344-3433
(Address of principal executive offices)
(952) 943-6000
(Registrant’s telephone number, including
area code)
Not applicable
(Former name or former address, if changed
since last report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 3.02.
|
Unregistered Sales of Equity Securities.
|
On September 14, 2016, EVINE Live Inc.
(the “Company”) entered into Securities Purchase Agreements (the “Purchase Agreements”) with certain accredited
investors pursuant to which it agreed to sell (i) shares of the Company’s common stock, (ii) warrants to purchase shares
of the Company’s common stock, and (iii) certain options to purchase additional shares of, and warrants to purchase shares
of, the Company’s common stock. The Company previously disclosed the details of this transaction (the “Transaction”)
by current report on Form 8-K filed September 15, 2016.
On January 23, 2017, one of the Company’s
investors exercised an option purchased as part of the Transaction. This exercise resulted in the issuance of (a) 978,604 shares
of the Company’s common stock, par value $0.01 per share; and (b) a warrant to purchase an additional 489,302 shares of the
Company’s common stock, par value $0.01 per share (the “Option Warrant”). The exercise price of the options was
$1.20 per share, resulting in aggregate proceeds of $1,174,324.58. The Option Warrant bears an exercise price of $1.76 per share,
and is exercisable for a five-year period expiring on January 23, 2022.
Please refer to Form 8-K filed September
15, 2016, for additional details on the Transaction, including additional terms related to exercise of the options and option warrants.
As discussed in that report, the Company has concluded that the sale of securities under the Purchase Agreements, and the issuance
of securities upon exercise of the options, was exempt from registration under Securities Act of 1933, as amended, pursuant to
Rule 506 of Regulation D, promulgated thereunder.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereto duly authorized.
Date: January 26, 2017
|
EVINE LIVE INC.
|
|
|
|
|
|
|
|
By:
|
/s/ Damon Schramm
|
|
|
Damon Schramm
Senior Vice President, General Counsel and Secretary
|
Evolv Technologies (NASDAQ:EVLV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Evolv Technologies (NASDAQ:EVLV)
Historical Stock Chart
From Jul 2023 to Jul 2024